Join Aligos Therapeutics for a virtual KOL event featuring Stephen Harrison, MD (Visiting Professor, Radcliffe Department of Medicine, University of…
Neurelis will host a 90-minute virtual investor call to highlight updates on two of its product candidates. NRL-1004 for Acute…

Join TScan Therapeutics for a virtual KOL event, featuring hematologist/oncologists Ran Reshef, MD, MSc (Columbia University Irving Comprehensive Cancer Center) and Monzr M. Al Malki,…
With anticipation building for the first clinical readouts expected later in 2024, join Kineta (KA: Nasdaq), Hummingbird Bioscience, and Geisel…
Join Annexon Biosciences for an overview of Guillain-Barré Syndrome (GBS), the most common cause of acute neuromuscular paralysis, featuring GBS…